Business Insider

ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician ...
Seeking Alpha

ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology

UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced today that its ...
Nasdaq

ProPhase Labs Inc. Establishes Clinical Science Advisory Board to Advance BE-SmartTM Test for Esophageal Disease Detection

ProPhase Labs Inc. has announced the formation of a Clinical Science Advisory Board to support the commercialization of its BE-Smart™ molecular test for esophageal disease, aimed at early detection ...
Nasdaq

ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART

Garden City, NY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the ...
Seeking Alpha

ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology

UNIONDALE, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) today announced that its study, “Assessing Risk of Progression in Barrett’s Esophagus Using a Mass-Spectrometry-Based ...